Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature

被引：0

作者：

Salman, Andac ^{[1
]}

Aktas, Meryem ^{[1
]}

机构：

[1] Marmara Univ, Dept Dermatol, Sch Med, Istanbul, Turkey

来源：

ASTIM ALLERJI IMMUNOLOJI | 2021年 / 19卷 / 02期

关键词：

Chronic spontaneous urticaria; omalizumab; pregnancy; updosing;

D O I：

10.21911/aai.599

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Omalizumab is a safe and effective treatment option for chronic spontaneous urticaria (CSU). Although cohort studies in patients with asthma show no increased risk of congenital abnormalities, very little data exist in the literature regarding the use of omalizumab for CSU during pregnancy. Herein, the safe and successful use of omalizumab updosing in a pregnant woman with CSU along with a review of the published literature is presented.

引用

页码：114 / 117

页数：4

共 13 条

[1]

Cuervo-Pardo L, 2016, EUR ANN ALLERGY CLIN, V48, P145

[2] Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment [J].

Curto-Barredo, Laia ;

Riba Archilla, Laura ;

Roura Vives, Guillem ;

Pujol, Ramon M. ;

Gimenez-Arnau, Ana M. .

ACTA DERMATO-VENEREOLOGICA, 2018, 98 (07) :641-647

[3] Omalizumab as Third-Line Therapy for Urticaria During Pregnancy [J].

Ensina, L. F. ;

Cusato-Ensina, A. P. ;

Camelo-Nunes, I. C. ;

Sole, D. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2017, 27 (05) :326-327

[4] Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies [J].

Ghazanfar, Misbah Nasheela ;

Thomsen, Simon Francis .

CASE REPORTS IN MEDICINE, 2015, 2015

[5] Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases [J].

Gonzalez-Medina, M. ;

Curto-Barredo, L. ;

Labrador-Horrillo, M. ;

Gimenez-Arnau, A. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (05) :e245-e246

[6]

Kocaturk E, 2020, ALLERGY, V75, P5

[7] The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU [J].

Maurer, M. ;

Abuzakouk, M. ;

Berard, F. ;

Canonica, W. ;

Elberink, H. Oude ;

Gimenez-Arnau, A. ;

Grattan, C. ;

Hollis, K. ;

Knulst, A. ;

Lacour, J-P ;

Lynde, C. ;

Marsland, A. ;

McBride, D. ;

Nakonechna, A. ;

Ortiz de Frutos, J. ;

Proctor, C. ;

Sussman, G. ;

Sweeney, C. ;

Tian, H. ;

Weller, K. ;

Wolin, D. ;

Balp, M-M. .

ALLERGY, 2017, 72 (12) :2005-2016

[8] Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence [J].

Metz, Martin ;

Vadasz, Zahava ;

Kocaturk, Emek ;

Gimenez-Arnau, Ana M. .

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 59 (01) :38-45

[9] Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort [J].

Namazy, Jennifer A. ;

Blais, Lucie ;

Andrews, Elizabeth B. ;

Scheuerle, Angela E. ;

Cabana, Michael D. ;

Thorp, John M. ;

Umetsu, Dale T. ;

Veith, Joachim H. ;

Sun, Diana ;

Kaufman, Derrick G. ;

Covington, Deborah L. ;

Mukhopadhyay, Santanu ;

Fogel, Robert B. ;

Lopez-Leon, Sandra ;

Spain, C. Victor .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) :528-+

[10]

Tharp MD., 2018, JAMA DERMATOL, V02467, P1

← 1 2 →